EXPERIENCE IN TREATMENT OF PATIENTS WITH H. PYLORI-ASSOCIATED DISEASES

EXPERIENCE IN TREATMENT OF PATIENTS WITH H. PYLORI-ASSOCIATED DISEASES

Efforts are under way to find optimal therapy for Helicobacter pylori (H. Pylori)-associated gastrointestinal diseases. Among such diseases are gastric and duodenal ulcers, gastritis (atrophic gastritis), functional dyspepsia, gastropathies induced by non-steroidal antiulcer drugs (NSAIDs). Various...

Full description

Bibliographic Details
Main Author:	S. A. Bulgakov
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2018-01-01
Series:	Медицинский совет
Subjects:	bismuth products novobismol® hp-associated diseases treatment
Online Access:	https://www.med-sovet.pro/jour/article/view/2238

Similar Items

USE OF BISMUTH DRUGS IN THERAPY OF GASTROENTEROLOGIC PATIENTS AND IN ERADICATION SCHEMES TAKING INTO ACCOUNT MAASTRICHT V RECOMMENDATIONS
by: O. N. Minushkin, et al.
Published: (2017-11-01)

European Registry on the management of Helicobacter pylori infection: features of diagnosis and treatment in Kazan
by: S. R. Abdulkhakov, et al.
Published: (2020-09-01)

European registry on Helicobacter pylori management (Hp-EuReg) as a tool to evaluate and improve clinical practice in Moscow
by: D. S. Bordin, et al.
Published: (2020-02-01)

Underwater rocks of anti - helicobacter therapy
by: M A Livzan
Published: (2019-08-01)

Helicobacter-pylori Negative Gastritis in Children—A New Clinical Enigma
by: Yoram Elitsur, et al.
Published: (2014-10-01)

MONITORING OF CASES WITH A CHRONIC PERSISTENT INFECTION WITH HELICOBACTER PYLORI
by: Miglena Stamboliyska, et al.
Published: (2014-09-01)

Evaluation of Helicobacter Pylori eradication in pediatric patients by triple therapy plus lactoferrin and probiotics compared to triple therapy alone
by: Tolone Salvatore, et al.
Published: (2012-10-01)

Role of Helicobacter pylori in Rosacea
by: Nazan EMİROĞLU, et al.
Published: (2018-01-01)

Pharmacoeconomic evaluation of treatment in patients with Helicobacter pylori-associated diseases
by: A A Samsonov, et al.
Published: (2014-08-01)

Treatment of Helicobacter pylori-Associated Diseases in Ukraine. The Place of Colloidal Bismuth Subcitrate in the Combination Therapy of These Patients
by: A.E. Dorofeiev, et al.
Published: (2015-11-01)

Endocytotic uptake of FITC- labeled anti-H. pylori egg yolk immunoglobulin Y in Candida yeast for detection of intracellular H. pylori
by: Parastoo eSaniee, et al.
Published: (2015-02-01)

European Registry on the management of Helicobacter pylori infection (Hp-EuReg protocol): The first results of Russian centers
by: D S Bordin, et al.
Published: (2016-02-01)

Evropeyskiy registr Helicobacter pylori (Hp-EuReg): analiz dannykh 2360 bol'nykh, poluchavshikh terapiyu pervoy linii v Rossii
by: D S Bordin, et al.
Published: (2018-02-01)

Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for Helicobacter pylori infection
by: Chang Seok Bang, et al.
Published: (2020-09-01)

Transcriptional profiling of type II toxin-antitoxin genes of Helicobacter pylori under different environmental conditions: identification of HP0967-HP0968 system
by: MIGUEL A DE LA CRUZ, et al.
Published: (2016-11-01)

The efficacy and safety of quadruple therapy without bismuth (concomitant therapy) in the treatment of patients with Helicobacter pylori - associated gastric and duodenal peptic ulcer disease
by: A M Veliev, et al.
Published: (2019-08-01)

Active <i>Helicobacter pylori</i> Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients
by: Michael Doulberis, et al.
Published: (2020-03-01)

Evaluation of the Direct Economic Cost per Eradication Treatment Regimen against <i>Helicobacter pylori</i> Infection in Greece: Do National Health Policy-Makers Need to Care?
by: Christos Liatsos, et al.
Published: (2020-03-01)

The effectiveness of H. pylori therapy in patients with helicobacter pylori related functional dyspepsia
by: I. V. Mayev, et al.
Published: (2014-12-01)

Developing adapter for importing data from external sources
by: M. V. Sterjanov
Published: (2019-06-01)

Correlation of serum Hp-specific antibody and anti-HP-CagA antibody with coronary artery lesions in patients with coronary heart disease
by: Wei Yu, et al.
Published: (2018-09-01)

A Decade of Effective Dry Eye Disease Management with Systane Ultra (Polyethylene Glycol/Propylene Glycol with Hydroxypropyl Guar) Lubricant Eye Drops
by: Srinivasan S, et al.
Published: (2021-06-01)

Therapeutic efficacy of ranitidine bismuth citrate with clarithromycin for seven days in the eradication of Helicobacter pylori in Brazilian peptic ulcer patients
by: Jaime Natan Eisig, et al.

The complete genome and methylome of Helicobacter pylori hpNEAfrica strain HP14039
by: Binit Lamichhane, et al.
Published: (2019-02-01)

LAUMONIERA H.P. NOOTEBOOM (SIMAROUBACEAE) REDUCED TO BRUCE A J.F. MILL.
by: A.J.G.H. KOSTERMANS
Published: (2014-01-01)

Effect of Helicobacter pylori eradication on insulin resistance among prediabetic patients: A pilot study and single-blind randomized controlled clinical trial
by: Ali Kachuei, et al.
Published: (2016-01-01)

The Efficacy of Bismuth-containing Quadruple Therapy after Moxifloxacin-based Sequential Therapy Failure in Helicobacter pylori Eradication
by: Soohoon Kwon, et al.
Published: (2018-04-01)

Synthesis and molecular structure of the novel bismuth(III) sulfonate complex [Bi(C18H14P(O)SO3)2(DMSO)3](NO3)∙DMSO∙2H2O
by: Schlesinger Maik, et al.
Published: (2012-12-01)

Colloidal Bismuth Subcitrate in the Treatment of Helicobacter Pylori Infection
by: A.E. Dorofeiev, et al.
Published: (2016-02-01)

A Decrease of Histone Deacetylase 6 Expression Caused by Helicobacter Pylori Infection is Associated with Oncogenic Transformation in Gastric Cancer
by: Qing He, et al.
Published: (2017-07-01)

Inefficacy of triple therapy and comparison of two different bismuth-containing quadruple regimens as a firstline treatment option for helicobacter pylori
by: Murat Kekilli, et al.
Published: (2016-01-01)

Effect of 7-day Bismuth Quadruple Therapy versus 14-day Moxifloxacin Triple Therapy for Second-line Helicobacter pylori Eradication Therapy
by: Sung Eun Kim, et al.
Published: (2019-01-01)

In vitro and in vivo inhibition of Helicobacter pylori by Lactobacilllus paracasei HP7
by: Seong-Soo Hong, et al.
Published: (2018-12-01)

Philosophische Tugenden Eine Verteidigung von J. S. Mills Philosophie der praktischen Philosophi
Published: (2020)

Helicobacter pylori: what schemes of eradication are essential today?
by: Igor' Veniaminovich Maev, et al.
Published: (2011-08-01)

In vitro effect of aspirin on Helicobacter pylori on upper gastrointestinal tract
by: Madhurima Kothapalli, et al.
Published: (2015-01-01)

Comparison of the impact of Helicobacter pylori eradication treatment with bismuth and non-bismuth quadruple regimens on the gut microbiota
by: S. Prast-Nielsen, et al.
Published: (2019-11-01)

Single Capsule Bismuth Quadruple Therapy for Eradication of H. pylori Infection: A Real-Life Study
by: Antonietta G. Gravina, et al.
Published: (2021-04-01)

European registry Helicobacter pylori (Hp-EuReg): how has clinical practice changed in Russia from 2013 to 2018 years
by: D S Bordin, et al.
Published: (2019-02-01)

Analysis of Helicobacter pylori infection in patients with oral lichen planus
by: YAO Xiaowu, et al.
Published: (2017-11-01)